Amarjeet S Bains, MD | |
1600 North Main, Lovington, NM 88260-2813 | |
(575) 396-6611 | |
(575) 396-0318 |
Full Name | Amarjeet S Bains |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1600 North Main, Lovington, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962446203 | NPI | - | NPPES |
26927 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 94184 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amarjeet S Bains, MD 1600 North Main, Lovington, NM 88260-2813 Ph: (575) 396-6611 | Amarjeet S Bains, MD 1600 North Main, Lovington, NM 88260-2813 Ph: (575) 396-6611 |
News Archive
Separating out particular kinds of cells from a sample could become faster, cheaper and easier thanks to a new system developed by MIT researchers that involves levitating the cells with light.
Scientists have uncovered a change in the H5N1 bird flu virus which makes it resistant to the anti-viral drug Tamiflu. The mutation in the N1 component was found in human cases of the disease and suggests that a single drug approach is likely to be ineffective in case of a bird flu pandemic in humans. The findings by a team at the Medical Research Council's National Institute for Medical Research are published in Nature.
A research team led by University of Washington scientists has found that several people in South and Southeast Asian countries working and living around monkeys have been infected with simian foamy virus (SFV), a primate virus that, to date, has not been shown to cause human disease.
Published in the Journal of Controlled Release, researchers from the German University in Cairo, and the University of Cologne, looked into nano-reformulation of repurposed antiviral and immune-modulating drugs for inhalation therapy against COVID-19. In addition, they focused on how nanomedicine could address the limitations of current therapeutics, enhancing the efficacy, specificity, and safety of such drugs.
› Verified 5 days ago